Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-05 12:23 pm Sale | 2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -3,708,838 (Position Closed) | Filing |
| 2023-02-14 12:12 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% | 936,776 (+33.79%) | Filing |
| 2021-12-23 5:28 pm Purchase | 2021-12-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 2,772,062 5.600% | 2,772,062 (New Position) | Filing |